コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 nel and kinetics of glycine binding with its ligand binding domain.
2 R (hPXR) by interacting with its promiscuous ligand binding domain.
3 ed folding of full-length transcripts of the ligand binding domain.
4 with binding hot spots within the PPARgamma ligand binding domain.
5 nts and cocrystallization with the RORgammat ligand binding domain.
6 ine-rich nuclear export signals (NES) in its ligand binding domain.
7 nt missense mutations in the Dalpha7 nAChR's ligand binding domain.
8 ed recruitment of cofactor motifs to the FXR-ligand binding domain.
9 ation of truncated AR protein that lacks the ligand binding domain.
10 nd UT-155) also binding the carboxy-terminal ligand binding domain.
11 by insertion of the estrogen receptor-alpha ligand-binding domain.
12 fferences in the quaternary structure of the ligand-binding domain.
13 nd the beta8-beta9 loop in the extracellular ligand-binding domain.
14 dues facing the heterodimer interface of the ligand-binding domain.
15 (GR) GRalpha, as the GRbeta isoform lacks a ligand-binding domain.
16 ardants and dust extracts to human PPARgamma ligand-binding domain.
17 mprove key interactions with the human GluA2 ligand-binding domain.
18 ovo amino acid substitutions, all within the ligand-binding domain.
19 ller structure resembling the alpha-integrin ligand-binding domain.
20 en receptor (AR) splice variants lacking the ligand-binding domain.
21 activated by targeting a site outside of its ligand-binding domain.
22 binding of glutamate to a solvent-accessible ligand-binding domain.
23 EID1 mimics helix H1 of the nuclear receptor ligand-binding domain.
24 receptor assembly, driven by closure of the ligand-binding domain.
25 AFs), AF-1 in the N-terminal and AF-2 in the ligand-binding domain.
26 hrough a pathway that bypasses its canonical ligand-binding domain.
27 truncated AR variant proteins lacking the AR ligand-binding domain.
28 on based on the crystal structures of the MR ligand-binding domain.
29 ng by selectively interacting with the GluA2 ligand-binding domain.
30 ee clinically relevant GR modulators from GR ligand binding domains.
31 n, suggesting uncoupling of the pore and the ligand binding domains.
32 ion channel and linkers connecting it to the ligand-binding domains.
33 , where these domains frequently function as ligand-binding domains.
34 RNA splicing to produce isoforms with 1 or 2 ligand-binding domains.
35 interactions between the amino-terminal and ligand-binding domains.
36 nal rearrangements of the amino-terminal and ligand-binding domains.
37 sion system was used to express SdrF and its ligand-binding domains.
40 lical proteins that consist of a periplasmic ligand-binding domain; a transmembrane region; a cytopla
42 promotes conformational changes in the EphA4 ligand-binding domain allowing the formation of signalin
43 onocytes also express Siglec-14, which has a ligand-binding domain almost identical to Siglec-5 but s
44 Rbeta antibodies, we showed that an in-frame ligand binding domain and C terminus were present in the
45 t formed by the interface of two neighboring ligand binding domains and act by stabilizing the agonis
47 that some MODY1 mutations, positioned on the ligand-binding domain and hinge regions of the receptor,
48 of an electrostatic interaction between the ligand-binding domain and linker region to the pore that
49 explanation for this discrepancy is that the ligand-binding domain and NCoR1 peptides used for in vit
50 on of diverse AR variant species lacking the ligand-binding domain and possessing ligand-independent
52 nisms: firstly, by direct binding to Nurr1's ligand-binding domain and promoting its transcriptional
53 r composed of the alpha7 nAChR extracellular ligand-binding domain and the transmembrane domain of al
54 olling the tension of the linker between the ligand-binding domain and the transmembrane ion channel
55 alternatively spliced isoform that lacks the ligand-binding domain and thus no longer localizes at th
56 he formation of an active catalytic, but not ligand-binding domain, and that mutations that inhibit t
59 es of these compounds in the zebra fish zVDR ligand binding domain as complexes with NCoA-2 coactivat
60 fied, full-length LRH-1, as well as isolated ligand binding domain, bound to PGC1alpha with higher af
61 ative splicing and retains the extracellular ligand binding domain but lacks the intracellular signal
62 n monocytes and neutrophils, share identical ligand-binding domains but have opposing signaling funct
63 l transactivation domain, and the C-terminal ligand binding domain, but not the DNA-binding domain of
64 ess-type MMTV integration site family member-ligand-binding domain, but lacks the transmembrane domai
65 racterized AF2 interaction surface in the GR ligand-binding domain, but Lin11, Isl-1, Mec-3 (LIM) dom
66 tudies revealed an essential role for the GR ligand-binding domain, but no clear requirement for liga
68 lly for F-actin binding proteins, the DNGR-1 ligand binding domain contacts three actin subunits heli
69 ctivator peptide binds to the human RXRalpha ligand binding domain containing two clinically relevant
70 easurements reveal that interactions between ligand-binding domains control the conformational rearra
72 c-finger DNA-binding domain and the putative ligand-binding domain decrease NR2F1 transcriptional act
73 ects 9cRA-induced coactivator binding to the ligand binding domain demonstrated that UVI3003 signific
74 its high constitutive activity, both direct (ligand-binding domain-dependent) and indirect activation
75 mational change in a loop on the side of the ligand-binding-domain dimer, which leads to the formatio
76 ents in the AMPAR extracellular domain, with ligand-binding domain dimers losing their local 2-fold r
77 and antiestrogen resistance and suggest that ligand-binding domain dysfunction leads to endocrine the
78 conformational changes of the extracellular ligand-binding domains (ECDs) associated with receptor a
79 ansfected partial receptor consisting of the ligand binding domain (ER-bla; ERalpha beta-lactamase ce
80 activated fusion protein, which contains the ligand binding domain from a target NHR (human thyroid r
81 stitutive activity reveals uncoupling of the ligand-binding domain from conserved connector residues,
82 interactions of RID1 and RID2 with 20 other ligand-binding domains from different NR subtypes were o
83 drives these conformations, we decoupled the ligand-binding domains from specific transmembrane segme
84 ring in the portion of the gene encoding the ligand-binding domain, functionally suppressed RARA-medi
86 n fluorescent protein (GFP) insertion into a ligand-binding domain, generating the requisite alloster
87 ring (SAXS) experiments using isolated GluA2 ligand-binding domain (GluA2-LBD) are consistent with bi
88 data for 7-CKA binding to the isolated GluD2 ligand binding domain (GluD2-LBD), we find that binding
89 antagonism, the crystal structure of the GR ligand-binding domain (GR LBD) complex with a nonsteroid
92 vivo whereas adding another mutation in the ligand-binding domain (I634A) severely compromises homod
93 seudo-four-fold symmetric arrangement of the ligand-binding domains, illustrating subtle changes in s
94 The crystal structure of the zebrafish VDR ligand binding domain in complex with LCA and the SRC-2
95 odulators were cocrystallized with the GluA2 ligand binding domain in order to decipher the impact of
96 bimagrumab binds to both ActRIIA and ActRIIB ligand binding domains in a competitive manner at the cr
97 ystal structures of the human and insect TLX ligand-binding domain in complex with Atro box peptides.
98 t the crystal structure of the zebrafish VDR ligand-binding domain in complex with the ZK168281 antag
99 ve solved the crystal structure of the GluN1 ligand-binding domain in complex with TK40 and show that
100 reduces coactivator interaction with the CAR ligand-binding domain in mammalian two-hybrid assays; an
101 conserved in all x-ray structures of the RXR ligand-binding domain in the presence of agonist and coa
102 hydrogen bonds in the GluA2 (AMPA receptor) ligand-binding domain in the presence of several full an
107 on Model", which demonstrates how two tandem ligand-binding domains interact to regulate protein func
108 apping at two sites in the lower lobe of the ligand binding domain is consistent with deformation of
109 assays revealed that His323 of the PPARgamma ligand binding domain is important for binding to S1P.
110 tanding of how ADPR interacts with the TRPM2 ligand binding domain is lacking, hampering the rational
111 f the beta11-12 linker in the extracellular, ligand-binding domain is an integral component of the de
114 st binding modulates the conformation of the ligand-binding domain "layer" of the intact receptors an
115 pressed in prostate cancer (PCa) lack the AR ligand binding domain (LBD) and function as constitutive
116 f human NR5A1 (steroidogenic factor-1, SF-1) ligand binding domain (LBD) bound to PIP2 and PIP3 show
117 stic fashion, i.e., helix 12 not sealing the ligand binding domain (LBD) effectively, and therefore r
118 show how competitive antagonists rupture the ligand binding domain (LBD) gating "ring," how agonists
119 xible protein residues (pREST region) in the ligand binding domain (LBD) has considerably improved th
120 pe III domain ((10)Fn3), that target the PXR ligand binding domain (LBD) interactions with the steroi
122 teractions of various ligands within the AhR ligand binding domain (LBD) may contribute to differenti
124 currences harbor activating mutations in the ligand binding domain (LBD) of ER, which have been shown
125 model examining the interaction between the ligand binding domain (LBD) of RORalpha or RORgamma with
127 to monitor structural rearrangements in the ligand binding domain (LBD) of the mGluR7/7 homodimer re
128 ructure, starting with the first view of the ligand binding domain (LBD) published in 1998, and in ma
129 ystal structure of compound 10 within the GR ligand binding domain (LBD) unveils a novel binding conf
130 igands bind directly to recombinant RORgamma ligand binding domain (LBD), promote recruitment of a co
134 controlled by conformational changes in the ligand binding domain (LBD); however, glutamate receptor
135 the toxin acts like a straightjacket on the ligand-binding domain (LBD) "gating ring," restraining t
136 r, we biochemically reconstituted the GLR3.3 ligand-binding domain (LBD) and analyzed its selectivity
138 ators bind within the dimer interface of the ligand-binding domain (LBD) and stabilize the agonist-bo
139 es binding of neurotransmitter agonists to a ligand-binding domain (LBD) and structural rearrangement
140 ARs, we manipulated the coupling between the ligand-binding domain (LBD) and the ion channel by inser
141 eptor splicing variants (ARVs) that lack the ligand-binding domain (LBD) are associated with the deve
142 hus, endocrine therapies that inhibit the AR ligand-binding domain (LBD) are effective in treating PC
145 of the GluA2 AMPA subtype glutamate receptor ligand-binding domain (LBD) dimers to characterize a nat
147 of YSA and SWL with the extracellular EphA2 ligand-binding domain (LBD) has for many years precluded
148 tal structures of GluN1/GluN2A NMDA receptor ligand-binding domain (LBD) heterodimers in complex with
149 mined the crystal structure of the PPARgamma ligand-binding domain (LBD) in complex with VSP-51, whic
150 t stability of the D1 dimer interface in the ligand-binding domain (LBD) is an important determinant
151 static interactions at the apex of the AMPAR ligand-binding domain (LBD) is essential for gating by p
153 tal structures of the key analogue 2i in the ligand-binding domain (LBD) of GluA2 and GluK3 were dete
154 tallography reveals that SJB7 resides in the ligand-binding domain (LBD) of hPXR, interacting with th
156 nding pocket in the C-terminal region of the ligand-binding domain (LBD) of RORgammat was discovered
157 , we report the structure of the periplasmic ligand-binding domain (LBD) of the transmembrane chemore
158 ined the effects of mutations within the AhR ligand-binding domain (LBD) on the activity of diverse A
159 forms the ion channel, the membrane-proximal ligand-binding domain (LBD) that binds agonists such as
160 prototypical iGluR, reveals a clamshell-like ligand-binding domain (LBD) that closes in the presence
162 nnects the DNA-binding domain (DBD) with the ligand-binding domain (LBD) via a mix of positively char
164 l domains: an amino-terminal domain (ATD), a ligand-binding domain (LBD), a channel-forming transmemb
165 ses harbored mutations of ESR1 affecting its ligand-binding domain (LBD), all of whom had been treate
166 omposed of an amino terminal domain (ATD), a ligand-binding domain (LBD), and a transmembrane domain
167 R is activated by androgens that bind to its ligand-binding domain (LBD), causing the transcription f
168 amolecular interaction between CAR's DBD and ligand-binding domain (LBD), enabling the homodimer-hete
169 hrough their modulation of the extracellular ligand-binding domain (LBD), less is known about their r
170 It is activated by androgens through its ligand-binding domain (LBD), which consists predominantl
172 membrane-distal N-terminal domain (NTD) and ligand-binding domain (LBD), which is fused to the ion c
173 rs by stabilizing the apo state of the GluN1 ligand-binding domain (LBD), which is incapable of trigg
179 ated that many bacterial chemoreceptors have ligand-binding domains (LBD) of the dCACHE family, a str
180 ors (GPCRs) that contain large extracellular ligand binding domains (LBDs) and form constitutive dime
181 lar dynamics simulations of GluN1 and GluN2B ligand binding domains (LBDs) of NMDARs to investigate t
184 aised by the presence of large extracellular ligand-binding domains (LBDs) and constitutive homo/hete
186 those produced by NMDAR mutants in which the ligand-binding domains (LBDs) are locked in the closed c
188 tal structures of the ML032222a and PbiGluR3 ligand-binding domains (LBDs) reveal endogenous glycine
191 tor (MR) on Ser-843, a residue placed on the ligand binding domain, lowers affinity for agonists, pro
192 s missense variants within amino terminal or ligand-binding domains (misATD+LBD) and null variants le
193 galactomannoprotein antigen with two tandem ligand-binding domains (Mp1p-LBD1 and Mp1p-LBD2), was fo
195 nd-dependent transactivation function in the ligand binding domain of ERalpha C terminus (AF-2) and a
196 endometrial cancer mutation that alters the ligand binding domain of ESR1, while epitope tagging the
197 o probe the conformation of the desensitized ligand binding domain of functioning AMPAR complexes.
200 y assay showed that PB directly binds to the ligand binding domain of hPXR (K(D) = 1.42 x 10(-05)).
204 fusion of the Zif268 DNA binding domain, the ligand binding domain of the human estrogen receptor and
205 crystal structure of an agonist bound to the ligand binding domain of the PPARalpha receptor have bee
206 analyses reveal that 7j occupies the typical ligand binding domain of the PPARgamma agonists with, ho
207 X-ray studies of four rexinoids bound to the ligand binding domain of the retinoid X receptor reveal
210 iquitin ligase, interacts with the hinge and ligand binding domains of PPARgamma and is a bona fide E
211 lecule positive allosteric modulators of the ligand-binding domain of (S)-2-amino-3-(3-hydroxy-5-meth
212 teract with a binding site distinct from the ligand-binding domain of apoER2 for selenium delivery.
217 romoted the direct binding of LXRbeta to the ligand-binding domain of ERalpha and initiated an extran
218 ncluding those with hotspot mutations in the ligand-binding domain of ERalpha, remain dependent on ER
219 loop connecting Helix 11 and Helix 12 in the ligand-binding domain of ERalpha, which leads to a stabi
220 we utilize chimeric constructs, in which the ligand-binding domain of GluD1 is replaced by that of Gl
221 design using X-ray crystal structures of the ligand-binding domain of human GluA2 led to the discover
222 rimetry (ITC) analyses demonstrated that the ligand-binding domain of MCP2901 (MCP2901LBD) bound to c
223 their extracellular binding domains with the ligand-binding domain of metabotropic glutamate receptor
226 We found that AA binds to and stabilizes the ligand-binding domain of peroxisome proliferator-activat
227 hown that heme decreases the affinity of the ligand-binding domain of Rev-erb NRs for NCoR1 peptides.
228 re, we report the crystal structures for the ligand-binding domain of RORgammat in both apo and ligan
230 resent the crystal structure of the isolated ligand-binding domain of the GluN1-GluN2A NMDA receptor
231 % sequence similarity with the extracellular ligand-binding domain of the human alpha7 nAChR, to inve
233 of non-steroidal ligands able to bind to the ligand-binding domain of the MR and recruit different co
234 uch as the acetylcholine-binding protein and ligand-binding domain of the nAChR alpha9 subunit, we sy
236 ng products lacking the entire extracellular ligand-binding domain of the receptor while retaining th
237 g of GK-15 into the N-terminal extracellular ligand-binding domain of the umami (T1R) receptor was pe
238 of a leucine by threonine in helix 8 of the ligand-binding domain of the zebrafish MR confers the an
240 tructures for the soluble amino-terminal and ligand-binding domains of glutamate receptor ion channel
243 (AChBPs) are unique spatial homologs of the ligand-binding domains of nicotinic acetylcholine recept
245 udies reveal that only subtle changes in the ligand binding domain, often identified only in retrospe
246 rosine (Y) 537 amino acid residue within the ligand binding domain on (18)F-fluoroestradiol ((18)F-FE
248 and novel CAR designs that have alternative ligand binding domains or confer regulated function and/
250 viral DGR system targets putative tail fibre ligand-binding domains, potentially generating >10(18) p
251 s further modulated by ligand binding in the ligand-binding domain, providing evidence for Pin1-depen
252 etion of a conserved, unique sequence in the ligand binding domain (PXR174-210) did not interact with
253 GAMP, leads to a 180 degrees rotation of the ligand-binding domain relative to the transmembrane doma
256 sites at lysine 122 and 275 in the AF-1 and ligand binding domains, respectively, of FXR were subjec
258 ar docking analysis of PioOH-bound PPARgamma ligand-binding domain revealed an altered hydrogen bondi
260 ntagonist AP5; crystallization of the KaiR1D ligand-binding domain reveals that these ligands stabili
263 Recombinant soluble molecules displaying ligand-binding domains show marked quantitative and qual
264 h brace the heterodimer interface within the ligand binding domain, stabilize actively gating recepto
265 ulated ectodomain cleavage that releases the ligand-binding domain (sTie2) into the circulation.
267 have additional intersubunit contacts in the ligand binding domain that occur at both conserved and n
268 C-terminal angiopoietin domains to the Tie2 ligand-binding domain, the mechanisms for Tie2 activatio
269 olubility and stability of an active ERRbeta ligand-binding domain, thereby providing a protein tool
271 nd JH, which has been mapped to a particular ligand-binding domain, thus establishing this bHLH-PAS p
272 together with in silico modeling of the AHR ligand binding domain to identify indole, a microbial tr
273 ACVR1-R206H and -G328R do not require their ligand binding domain to over-activate BMP signaling in
274 w approaches that use genotyping of the AHR1 ligand binding domain to screen for DLC sensitivity amon
275 ciable pre-complex, enabling its neighboring ligand binding domain to tightly clamp the two polypepti
277 number of riboswitches that utilize the same ligand-binding domain to regulate transcription or trans
278 ors can bind within a pocket adjacent to the ligand-binding domain to stabilize specific conformation
279 possibly a stretch of linker, connecting the ligand-binding domain to the fourth membrane-spanning se
281 e opportunities through the use of different ligand-binding domains to enable multiplexed genome regu
282 PAR region that links the four extracellular ligand-binding domains to the central ion channel in the
283 A of the C-terminal part of the periplasmic ligand-binding domain upon ligand occupancy in the citra
284 erved tertiary architectural elements of the ligand binding domain using an in vitro single-turnover
286 n rat brain membranes and the purified GluN1 ligand-binding domain using glycine site GluN1 radioliga
287 h a crystallographic analysis of the GluRIIB ligand binding domain, we use this system to characteriz
290 uctures of the three modulators in the GluK1 ligand-binding domain were determined, locating two modu
291 y BMP7 and were sensitive to deletion of the ligand binding domain, whereas the engineered ACVR1(Q207
292 ve splicing of the flip/flop cassette of the ligand-binding domain, which controls motions in the dis
293 ous conformations of the estrogen receptor's ligand-binding domain, which in turn produces differenti
294 soform encoded by splice variant 7 lacks the ligand-binding domain, which is the target of enzalutami
295 tion leads to a conformational change in the ligand-binding domain, which mimics the conformation of
296 es, the ion channels are closed, whereas the ligand-binding domains, which are physically coupled to
297 rthermore, two NES were characterized in the ligand binding domain, whose deletion caused Nurr1 to ac
298 ized state, when ligands remain bound at the ligand binding domain with the conformation similar to t
299 The nearly 150 crystal structures of VDR's ligand-binding domain with various vitamin D compounds a
300 domain arrangement consisting of individual ligand binding domains, with a defined higher order arch